TME PHARMA - 1H - Technical analysis published on 12/20/2024 (GMT)
- 47
- 0
Click here for a new analysis!
- Timeframe : 1H
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Additional analysis
Quotes
The TME PHARMA rating is 0.0818 EUR. The price registered an increase of +23.19% on the session with the lowest point at 0.0669 EUR and the highest point at 0.0818 EUR. The deviation from the price is +22.27% for the low point and 0% for the high point.A bullish gap was detected at the opening by the Central Gaps scanner. There are a lot of buyers and they have the upper hand in the very short term.
Opening Gap UP
Type : Bullish
Timeframe : Openning
So that you have an overall view of the price change, here is a table showing the variations over several periods:
New LOW record (5 years)
Type : Bearish
Timeframe : Weekly
Technical
Technical analysis of this 1H chart of TME PHARMA indicates that the overall trend is not clearly defined. The trend could quickly turn bullish due to the strong bullish signals currently being given by short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
In fact, 16 technical indicators on 18 studied are currently positioned bullish. But beware of excesses. The Central Indicators scanner currently detects this:
RSI indicator is overbought : over 70
Type : Neutral
Timeframe : 1 hour
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : 1 hour
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : 1 hour
Pivot points : price is over resistance 3
Type : Neutral
Timeframe : 1 hour
Ichimoku : price is over the cloud
Type : Bullish
Timeframe : 1 hour
No signals are given by Central Patterns, a market scanner specialised in chart patterns, resistances and supports.
There is also a Japanese candlestick pattern detected by Central Candlesticks that could mark the end of the current short-term trend:
Doji
Type : Neutral
Timeframe : 1 hour
S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|
ProTrendLines | 0.0624 | 0.0800 | 0.0818 | 0.0949 | 0.1184 | 0.1410 |
Change (%) | -23.72% | -2.20% | - | +16.01% | +44.74% | +72.37% |
Change | -0.0194 | -0.0018 | - | +0.0131 | +0.0366 | +0.0592 |
Level | Intermediate | Minor | - | Minor | Minor | Major |
Attention could also be paid to pivot points to set price objectives:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 0.0601 | 0.0613 | 0.0639 | 0.0651 | 0.0677 | 0.0689 | 0.0715 |
Camarilla | 0.0654 | 0.0657 | 0.0661 | 0.0664 | 0.0668 | 0.0671 | 0.0675 |
Woodie | 0.0607 | 0.0617 | 0.0645 | 0.0655 | 0.0683 | 0.0693 | 0.0721 |
Fibonacci | 0.0613 | 0.0628 | 0.0637 | 0.0651 | 0.0666 | 0.0675 | 0.0689 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 0.0381 | 0.0524 | 0.0662 | 0.0805 | 0.0943 | 0.1086 | 0.1224 |
Camarilla | 0.0722 | 0.0748 | 0.0773 | 0.0799 | 0.0825 | 0.0851 | 0.0876 |
Woodie | 0.0378 | 0.0523 | 0.0659 | 0.0804 | 0.0940 | 0.1085 | 0.1221 |
Fibonacci | 0.0524 | 0.0632 | 0.0698 | 0.0805 | 0.0913 | 0.0979 | 0.1086 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 0.0837 | 0.1053 | 0.1269 | 0.1485 | 0.1701 | 0.1917 | 0.2133 |
Camarilla | 0.1365 | 0.1405 | 0.1444 | 0.1484 | 0.1524 | 0.1563 | 0.1603 |
Woodie | 0.0836 | 0.1053 | 0.1268 | 0.1485 | 0.1700 | 0.1917 | 0.2132 |
Fibonacci | 0.1053 | 0.1218 | 0.1320 | 0.1485 | 0.1650 | 0.1752 | 0.1917 |
Numerical data
The following are the details of the technical indicators and moving averages that were collected to generate this technical analysis:
RSI (14): | 69.10 | |
MACD (12,26,9): | 0.0024 | |
Directional Movement: | 21.5852 | |
AROON (14): | 64.2857 | |
DEMA (21): | 0.0728 | |
Parabolic SAR (0,02-0,02-0,2): | 0.0664 | |
Elder Ray (13): | 0.0077 | |
Super Trend (3,10): | 0.0694 | |
Zig ZAG (10): | 0.0809 | |
VORTEX (21): | 1.1932 | |
Stochastique (14,3,5): | 95.47 | |
TEMA (21): | 0.0768 | |
Williams %R (14): | -0.54 | |
Chande Momentum Oscillator (20): | 0.0163 | |
Repulse (5,40,3): | 9.1696 | |
ROCnROLL: | 1 | |
TRIX (15,9): | 0.0228 | |
Courbe Coppock: | 32.79 |
MA7: | 0.0711 | |
MA20: | 0.1034 | |
MA50: | 0.1262 | |
MA100: | 0.1342 | |
MAexp7: | 0.0757 | |
MAexp20: | 0.0706 | |
MAexp50: | 0.0720 | |
MAexp100: | 0.0818 | |
Price / MA7: | +15.05% | |
Price / MA20: | -20.89% | |
Price / MA50: | -35.18% | |
Price / MA100: | -39.05% | |
Price / MAexp7: | +8.06% | |
Price / MAexp20: | +15.86% | |
Price / MAexp50: | +13.61% | |
Price / MAexp100: | -0% |
News
The latest news and videos published on TME PHARMA at the time of the analysis were as follows:
- TME Pharma Announces the Launch of Fully Guaranteed Public Offer for €2.6 Million Open Only to Shareholders to Enable Completion of Strategic Transactions by June 2025
- CORRECTING and REPLACING: TME Pharma Announces Corporate Strategy Update and Upcoming €2.6 Million Guaranteed Financing With Intention to Launch Public Offer Open Only to Shareholders to Enable Completion of Transactions ...
- TME Pharma Announces Corporate Strategy Update and Upcoming €2.6 Million Guaranteed Financing With Intention to Launch Public Offer Open Only to Shareholders to Enable Completion of Transactions Around NOX-A12 and NOX-E36 by June 2025
- TME Pharma Announces Poster Presentation by U.S. National Cancer Institute on CXCL12 Inhibition by NOX-A12 in Glioblastoma at 2024 SNO Annual Meeting
- TME Pharma N.V.: Half-yearly Report on the Liquidity Contract With Invest Securities
Add a comment
Comments
0 comments on the analysis TME PHARMA - 1H